期刊信息
主办:中国中医科学院中药研究所;中华中医药学会
主管:国家中医药管理局
ISSN:1005-9903
CN:11-3495/R
语言:中文
周期:半月
影响因子:1.817375
数据库收录:
北大核心期刊(2008版);北大核心期刊(2011版);北大核心期刊(2014版);北大核心期刊(2017版);化学文摘(网络版);中国科学引文数据库(2015-2016);中国科学引文数据库(2017-2018);中国科学引文数据库(2019-2020);日本科学技术振兴机构数据库;中国科技核心期刊;期刊分类:中药学
期刊热词:
药理
黑骨藤醇提取物调控急性痛风性关节炎模型大鼠(6)
【作者】网站采编
【关键词】
【摘要】[18] 陈庆,靳凤云,陈华国,等.苗族黑骨藤有效部位的筛选研究[J].中国民族民间医药杂志,2005(3):163-165. [19] KHANNA D, KHANNA PP, FITZGERALD JD, et al. 2012 American College
[18] 陈庆,靳凤云,陈华国,等.苗族黑骨藤有效部位的筛选研究[J].中国民族民间医药杂志,2005(3):163-165.
[19] KHANNA D, KHANNA PP, FITZGERALD JD, et al. 2012 American College of Rheumatology guidelines for management of gout. Part 2: therapy and antiinflammatory prophylaxis of acute gouty arthritis. Arthritis Care Res (Hoboken). 2012;64(10):1447-1461.
[20] CLEOPHAS MC, CRI?AN TO, JOOSTEN LA. Factors modulating the inflammatory response in acute gouty arthritis. Curr Opin ;29(2):163-170.
[21] LU X, ZENG R, LIN J, et al. Pharmacological basis for use of madecassoside in gouty arthritis: anti-inflammatory, anti-hyperuricemic,and NLRP3 inhibition. Immunopharmacol Immunotoxicol. 2019;41(2):277-284.
[22] DUMUSC A, SO A. Interleukin-1 as a therapeutic target in gout. Curr Opin Rheumatol. 2015;27(2):156-163.
[23] 江丹,熊金河,尚华.洛索洛芬钠对急性痛风性关节炎大鼠血清IL-1β和滑膜组织中NF-κB 蛋白表达的影响[J].郑州大学学报(医学版),2019,54(3):446-449.
[24] 周琦,张宁,卢芳,等.穿山龙总皂苷对痛风性关节炎大鼠关节炎滑膜IL-1β 及其信号转导通路的影响[J].中药药理与临床,2013,29(6):52-57.
[25] 胡亚彬,杨青,张传玉,等.中性粒细胞胞外诱捕网和氧化应激在痛风发病机制中的作用[J].国际免疫学杂志,2018,41(6):690-694.
[26] LIU Y, ZHAO Q, YIN Y, et al. Serum levels of IL-17 are elevated in patients with acute gouty arthritis. Biochem Biophys Res ;497(3):897-902.
[27] 李雪峰,刘育辰,刘刚.苗药黑骨藤化学成分及药理作用研究进展[J].中成药,2018,40(4): 904-912.
[28] 梁江,王乾宇,黄维琛,等.黑骨藤追风活络胶囊抑制CIA 大鼠滑膜组织NF-κB 表达并减轻关节炎症反应[J].细胞与分子免疫学杂志,2019,35(3):193-198.
[29] 黄明进,罗春丽,郭刚,等.黑骨藤抗类风湿性关节炎作用及其分子机制[J].中国实验方剂学杂志,2011,17(12):174-177.
[30] VIATOUR P, MERVILLE MP, BOURS V, et al. Phosphorylation of NFkappaB and IkappaB proteins: implication in cancer and Biochem Sci. 2005;30(1):43-52.
[31] ZHAO Z, TANG X, ZHAO X, et al. Tylvalosin exhibits anti-inflammatory property and attenuates acute lung injury in different models, possibly through suppression of NF-κB activation. Biochem Pharmacol. 2014;90(1):73-87.
[32] DHANASEKAR C, KALAISELVAN S, RASOOL M. Morin, a Bioflavonoid Suppresses Monosodium Urate Crystal-Induced Inflammatory Immune Response in RAW 264.7 Macrophages through the Inhibition of Inflammatory Mediators, Intracellular ROS Levels and NF-κB One. 2015;10(12):e0.
[33] LIN TH, PAJARINEN J, LU L, et al. NF-κB as a Therapeutic Target in Inflammatory-Associated Bone Diseases. Adv Protein Chem Struct ;107:117-154.
[34] HAYDEN MS, GHOSH S. NF-κB in immunobiology. Cell Res. 2011;21(2):223-244.
[35] WARD C, WALKER A, DRANSFIELD I,et al. Regulation of granulocyte apoptosis by NF-kappaB. Biochem Soc Trans. 2004;32(Pt3):465-467.
[36] PIOTROWSKA A, IZYKOWSKA I, PODHORSKA-OKO?óW M, et al. The structure of NF- kappaB family proteins and their role in Hig Med Dosw (Online). 2008;62:64-74.
[37] ESPíN-PALAZóN R, TRAVER D. The NF-κB family: Key players during embryonic development and HSC emergence. Exp Hematol. 2016;44(7):519-527.
[38] 陈刚,殷钟意,郑旭煦,等.丹皮酚改善大鼠痛风性关节炎与调节核因子κB 活化的关系研究[J].中国药理学通报,2018,34(12):1730-1735.
[39] SENFTLEBEN U, CAO Y, XIAO G, et al. Activation by IKKalpha of a second,evolutionary conserved, NF-kappa B signaling pathway. Science. 2001;293(5534):1495-1499.
[40] HAYDEN MS, GHOSH S. Regulation of NF-κB by TNF family Immunol. 2014;26(3):253-266.
[41] MELOCHE S, POUYSSéGUR J. The ERK1/2 mitogen-activated protein kinase pathway as a master regulator of the G1- to S-phase transition. ;26(22):3227-3239.
[42] 徐轶尔,于雪峰,陈水林,等.基于JNK 信号通路探讨豨莶草对痛风性关节炎影响[J].中国骨质疏松杂志,2017,23(10):1340-1345.
文章来源:《中国实验方剂学杂志》 网址: http://www.zgsyfjxzzzz.cn/qikandaodu/2021/0302/483.html